🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in the USA / NCT03848962
Recruiting Observational

Collection and Distribution of Biospecimens for Novel Research Uses

NCT03848962 · tracked via the Priya Life Science USA tracker
Sponsor
iSpecimen Inc
Phase
Observational
Started
2016-06-30
Last updated
2022-11-09

Condition(s) studied

CancerHealthyGastrointestinal ComplicationAutoimmune DiseasesInfectious DiseaseWomen's Health: High-Risk PregnancyDermatologic DiseaseBlood Disease

Study summary

iSpecimen aims to create a clinical partner network of hospitals, laboratories, academic institutions, and other healthcare organizations ("institutions") capable of providing researchers and educators ("researchers") with annotated biospecimens for use in biomarker discovery and validation; diagnostic test and instrumentation development and validation; therapeutics development; other medical research including the impact that various specimen collection and handling methods and conditions have on research results; and in education such as researcher or physician training (collectively "research").

Eligibility

Sex
ALL
Min age
1 Month
Max age
89 Years
Healthy volunteers
Accepted
Inclusion Criteria: * Individual is developmentally aged 7 years old and above for RUO collections (only) * Individual meets requirements of a current request for research materials from iSpecimen * If a blood collection will be performed as part of the screening process or RUO collection, the individual's health will be assessed by medical staff through medical record review, clinical exam, and/or the review of an updated medical history as provided by the participant * Individual has reviewed and signed a consent form for an RUO specimen collection if required as part of the research or if a minor or a person with diminished decision-making capacity, their parent/guardian or Legally Authorized Representative has reviewed and signed the consent form on their behalf. * Individual has reviewed and signed a consent form for remnant specimen usage in research if required as part of the research or if a minor or a person with diminished decision-making capacity, their parent/guardian or Legally Authorized Representative has reviewed and signed the consent form on their behalf Exclusion Criteria: * Subjects that do not meet the inclusion criteria outlined above.

Primary outcome measure(s)

Trial sites (2)

FacilityCityRegionStatus
iSpecimen Huntsville Alabama Recruiting
iSpecimen Lexington Massachusetts Active Not Recruiting

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT03848962 on ClinicalTrials.gov ↗ ← All trials in the USA